SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-15-001166
Filing Date
2015-03-31
Accepted
2015-03-31 17:06:49
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K fpmi10k_dec312014.htm 10-K 1434605
2 SECOND AMENDMENT TO LEASE AGREEMENT BETWEEN HILSSIDE SQUARE, LLC AND FLUOROPHARM leaseam.htm EX-10.13 26779
3 CONSENT OF WOLF & COMPANY, P.C. ex23-1.htm EX-23.1 2546
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 OF THE SECURITI ex31-1.htm EX-31.1 9443
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 OF THE SECURITI ex31-2.htm EX-31.2 10000
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 1350. ex32-1.htm EX-32.1 4692
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 1350. ex32-2.htm EX-32.2 5105
  Complete submission text file 0001415889-15-001166.txt   6335254

Data Files

Seq Description Document Type Size
8 fpmi-20141231.xml EX-101.INS 674010
9 fpmi-20141231.xsd EX-101.SCH 72059
10 fpmi-20141231_cal.xml EX-101.CAL 49276
11 fpmi-20141231_def.xml EX-101.DEF 124769
12 fpmi-20141231_lab.xml EX-101.LAB 400459
13 fpmi-20141231_pre.xml EX-101.PRE 288564
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-147193 | Film No.: 15740187
SIC: 2835 In Vitro & In Vivo Diagnostic Substances